Serum proteins like CEA and NSE, gene expression markers, namely, alpha enolase (ENO1 and ENO2), as well as glycoprotein AFP, have demonstrated clinical utility as circulating biomarkers for SCLC [5]. This evidence concerns the gene ENO2 and small cell lung carcinoma.